Ceres Nanosciences, Inc. — Form D
Ceres Nanosciences, Inc. of MANASSAS, VA, a company, filed a Form D exempt-offering notice with the SEC on 2017-02-07. The offering totals $9.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-02-07
- Form: D
- Accession: 0001697394-17-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $9.0M
- Amount sold: $3.0M
- Remaining: $6.0M
- Minimum investment: $100K
- Investors: 1
- Date of first sale: 2017-01-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-280188
Issuer
- Name: Ceres Nanosciences, Inc.
- CIK: 0001697394
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9460 Innovation Dr, MANASSAS, VA, 20110
- Phone: 800-615-0418
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Emanuel Petricoin III | Director | Manassas, VA |
| Thomas Dunlap | Executive Officer | Manassas, VA |
| Scott Gazelle | Director | Richmond, VA |
| Ross Dunlap | Director | Washington, DC |
| Ross Dunlap | Executive Officer | Washington, DC |
| Ian Wright | Director | Earleville, MD |
| Tom Miller | Director | Marco Island, FL |
| Emanuel Petricoin | Director | Gainesville, VA |
Other filings by this issuer (1)
More